New England’s ActivMed Practices & Research Conducts Phase 3 COVID-19 Vaccine Trial in Portsmouth, New Hampshire

Residents in Massachusetts and New Hampshire can now participate in the pivotal Phase 3 trial testing the COVID-19 vaccine developed at Oxford University and now sponsored by AstraZeneca, known as AZD1222. Conducted by ActivMed Practices & Research LLC, the trial...

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review

The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting with AstraZeneca’s AZD1222 or the “Oxford” vaccine. This committee is investigating the first batch of data on the vaccine...

Pin It on Pinterest